Driving Productivity Across The Antibody Manufacturing Workflow

Rising therapeutic antibody titers can increase productivity, but they can also expose limitations in harvest, clarification, and purification. Addressing these constraints requires a coordinated approach that connects upstream performance with downstream capacity, product quality, and manufacturing cost. Thermo Fisher Scientific experts share practical strategies for integrating upstream and downstream operations to improve throughput and support scalable commercial manufacturing. A detailed case study examines how innovative single-use harvest and clarification technologies can help reduce bottlenecks, while downstream process optimization approaches demonstrate opportunities to improve purification efficiency.

Explore how a more connected process strategy can help manufacturers manage higher titers, maintain product quality, and build greater flexibility into therapeutic antibody production.